Top Healthcare Stocks to Watch in 2026: Eli Lilly, Merck, AbbVie Lead Strong Buy Signals
Discover the top healthcare stocks to watch in 2026, including Eli Lilly, Merck, AbbVie, and leading biotech ETFs showing strong buy and breakout signals. Explore the latest healthcare market trends, bullish technical setups, and key investment opportunities shaping the sector this year.
by Kowsalya
Published May 27, 2026 | Updated May 27, 2026 | 📖 3 min read
Article continues below advertisement
The healthcare sector is back in focus in 2026 as several pharmaceutical, biotech, and healthcare ETF stocks flash strong technical buy signals. From obesity-drug giant Eli Lilly to defensive healthcare names like Johnson & Johnson and Merck, analysts and traders are closely tracking momentum, breakout patterns, and volume strength across the sector.
According to the latest healthcare stock screening data, multiple large-cap pharma companies and biotech plays are currently rated “Strong Buy,” supported by bullish momentum indicators, rising trend strength, and breakout setups.
Why Healthcare Stocks Are Trending in 2026
Healthcare stocks are attracting renewed investor attention due to:
- Rising demand for obesity and diabetes treatments
- Strong biotech innovation pipelines
- Defensive sector stability during market volatility
- Growing institutional inflows into healthcare ETFs
- AI-driven drug discovery and clinical research momentum
Major healthcare companies are also benefiting from improved earnings visibility and resilient demand for specialty medicines.
Best Healthcare Stocks Showing Strong Buy Signals
Here are some of the top healthcare and biotech stocks currently showing bullish technical setups based on the latest screening data.
| Stock | Current Signal | Key Trend | Technical Outlook |
|---|---|---|---|
| Eli Lilly (LLY) | Strong Buy | Breakout Momentum | Bullish continuation |
| Merck (MRK) | Strong Buy | Rising Trend | Pullback buy candidate |
| AbbVie (ABBV) | Strong Buy | Breakout Setup | Bullish but volatile |
| Bristol Myers Squibb (BMY) | Strong Entry | Breakout | Improving momentum |
| Gilead Sciences (GILD) | Strong Entry | Momentum | Stable bullish structure |
| Vertex Pharma (VRTX) | Strong Buy | Breakout | Range breakout watch |
| Amgen (AMGN) | Strong Buy | Breakout | Long-term bullish setup |
Eli Lilly (LLY) Remains the Healthcare Leader
Why LLY Stock Is Still Bullish
Eli Lilly continues to dominate healthcare stock discussions in 2026, driven by strong demand for weight-loss and diabetes drugs.
The screening report shows:
- Strong Buy rating
- Bullish breakout setup
- High-conviction volume confirmation
- RSI near overbought territory
- Positive trend continuation structure
However, the report also suggests tightening stop-loss levels because momentum indicators are nearing overheated conditions.
Merck (MRK) and AbbVie (ABBV) Showing Strong Momentum
Merck (MRK)
Merck continues to maintain bullish momentum with:
- Strong Buy rating
- Rising trend structure
- Positive breakout pattern
- Strong institutional volume support
AbbVie (ABBV)
AbbVie is also among the stronger healthcare performers despite broader sector volatility.
Key highlights include:
- Bullish trend structure
- Strong Buy signal
- Positive breakout formation
- Improving momentum indicators
Healthcare ETFs Also Showing Bullish Signals
Healthcare-focused ETFs are also attracting attention from investors looking for diversified exposure.
Top Healthcare ETFs to Watch
| ETF | Sector Focus | Current Outlook |
|---|---|---|
| XLV | Healthcare Select Sector SPDR | Strong Buy |
| VHT | Vanguard Health Care ETF | Strong Buy |
| IBB | iShares Biotechnology ETF | Bullish Setup |
| XBI | SPDR S&P Biotech ETF | Recovery Momentum |
| PPH | Pharmaceutical ETF | Breakout Watch |
Healthcare Stocks Facing Weakness in 2026
Not every healthcare stock is currently bullish.
The report flags several names as “Strong Sell” or “Avoid” because of ongoing downtrends and weak technical structures.
Stocks Under Pressure
- Regeneron (REGN)
- Sage Therapeutics (SAGE)
- HCA Healthcare (HCA)
- Molina Healthcare (MOH)
- Zoetis (ZTS)
Featured Snippet: Which Healthcare Stocks Are Best for 2026?
The top healthcare stocks showing the strongest bullish technical signals in 2026 include Eli Lilly (LLY), Merck (MRK), AbbVie (ABBV), Bristol Myers Squibb (BMY), Gilead Sciences (GILD), and Amgen (AMGN). Several healthcare ETFs like XLV and VHT are also showing strong institutional momentum.
Key Takeaways for Investors
Healthcare remains one of the most closely watched sectors in 2026 due to its combination of growth, innovation, and defensive characteristics.
While large-cap pharma stocks continue to dominate institutional flows, biotech and healthcare ETFs are also beginning to recover after periods of volatility.
Investors should still monitor:
- RSI overheating signals
- Risk-reward ratios
- Volume confirmation
- Breakout sustainability
- Trend continuation strength
Technical indicators currently favor selective healthcare leaders rather than broad-based sector buying.
Related Articles
Disclaimer : The above information is for general informational purposes only. All information on the Site is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information on the Site.